Taro Pharma: IsZo Capital writes again to the BoD

This letter from IsZo Capital does a great job of showing why the current buyout offer for Taro Pharma is extremely undervaluing the company. Also it does an amazing job in showing why the value of Taro Pharma is much higher than the current market price.

Leave a Reply

%d bloggers like this: